期刊文献+

肺动脉高压发病机制的研究进展

下载PDF
导出
摘要 肺动脉高压是一种临床常见病症,病因复杂,可由多种心、肺血管疾病引起,其发生过程是一个复杂的生理病理过程,发病机制尚未完全明了。本文就K+通道机制,血管活性因子失衡,分子遗传机制等方面对肺动脉高压的影响做一综述。
作者 邓敏
出处 《科技信息》 2011年第14期I0095-I0095,共1页 Science & Technology Information
  • 相关文献

参考文献12

  • 1Durmowicz AG,Parks WC,Hyde DM,et al.Persistence,re-expression,and Induction of pulmonary arterial fibronectin, tropoelastin,and type I procoUagen Mrna expression in neonatal hypoxic pulmonary hypertension [J].Am J Pathol,1994,145:1411-1420.
  • 2Stephen Archer,MD,Smart,MD. Primary Pulmonary Hypertension [J ].Circulation,2000 102:2781.
  • 3卢献灵,何建国.肺动脉高压的分类和研究进展[J].临床内科杂志,2008,25(10):653-657. 被引量:29
  • 4Perrella MA,Edell ES,rowka MJ,et al.Endothehum-derived relaxing factorin pulmonary and renal circulations during hypoxia [J ].Am J Physiol,1992,263(1Pt2):R45-50.
  • 5Ozaki MiKawashima S,Yamashita T,et a l.Reduced hypoxic pulmonaryvascular remodeling by nitric oxide from the endothelium [J ].Hypertension,2001,37(2):322-327.
  • 6王培勇,刘健,罗德成,许蜀闽,孙秉庸,陈兆珍.一氧化氮在缺氧肺动脉平滑肌细胞增殖中的作用[J].中国药理学通报,1997,13(5):476-477. 被引量:8
  • 7Christman BW,McPherson CD,Newman JH,et al.An imbalance between theexcretion of thromboxane and prostacyclin metabolites in pulmonaryhypertension[J ].N EnglJ Med,1992,327(2);70-75.
  • 8Li H,Chen SJ,hen YF,et al.Enhanced endothelin-1 and endothelin receptorgene expression in chronic hypoxia [J].Appl Physiol,1994,7 (3): 451-459.
  • 9Giaid A,Yanagisawa M,Langleben D,et al.Expression of endothelin-1 inthe lungs of patients with pulmonary hypertension [J].Engl J Med, 1993,28 (24): 1732-1739.
  • 10Langleben D.Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension[J ].Clin Chest Med,2007,28(1):117-125.

二级参考文献22

  • 1王培勇,孙秉庸.缺氧对平滑肌细胞生长特性、细胞内游离钙及环磷酸腺苷浓度的影响[J].第三军医大学学报,1995,17(1):11-14. 被引量:11
  • 2Rubin LJ. Pulmonary Arterial Hypertension. The Proceedings of the American Thoracic Society ,2006,3 : 111-115.
  • 3Hoeper MM, Rubin LJ. Update in Pulmonary Hypertension 2005. Am J Respir Crit Care Med ,2006,173:499-505.
  • 4Galie N ,Torbicki A. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European society of cardiology. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. European Heart Journal ,2004,25:2243-2278.
  • 5Mandegar M, Yuan JX. Role of K ^+ channels in pulmonary hypertension. Vascul Pharmacol,2002,38:25-33.
  • 6Firth AL, Yuill KH, Smimov SV. Mitochondria-dependent regulation of Kv currents in rat pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol,2008,295 : L61-70.
  • 7Park MH. Advances in diagnosis and treatment in patients with pulmonary arterial hypertension. Catheter Cardiovasc Interv, 2008,71 : 205- 213.
  • 8Hoshikawa Y, VoelkelNF, Gesell TL, et al. Prostacyclin receptor dependent modulation of pulmonary vascular remodeling. Am J Respir Crit CareMed,2001,164:314-318.
  • 9Mathew R, Huang J, Gewitz MH. Pulmonary artery hypertension : caveolin-1 and eNOS interrelationship:a new perspective. Cardiol Rev ,2007, 15 : 143-149.
  • 10Venema RC, Venema V J, Ju H. Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase. Am J Physiol Heart Circ Physiol,2003,285 : H669-678.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部